FERRIC CONTRAST

Based at the University at Buffalo Technology Incubator in Baird Research Park, Ferric Contrast is developing a novel family of iron-based MRI contrast agents... Ferric Contrast, Inc. is committed to building the safest MRI contrast agents available giving your physician a better tool to diagnose common and uncommon problems. Ferric Contrast is developing iron-based contrast agents that can be used to produce high-quality magnetic resonance images of the brain, vasculature, liver and kidneys, and for detection of tumors resulting from cancer. Our work has already garnered the attention of our peers, who are working to help us achieve our goals... Ferric Contrast, Inc. is a biotechnology company improving clinical usefulness of MRI scanners and building safer MRI contrast agents. Our lead candidate, MP89, will complete the non-clinical phase by the end of 2018 and we expect to have all the necessary pre-clinical work completed for an IND filing in 2019. Our other contrast agents, L410..

Also known as: Ferric Contrast, Inc.

Primary location: Amherst United States